When we analyzed the diabetes patients with CRD, it was found that the use of fast- and long-acting insulin increased gradually, whereas premixed and shorting- and intermediate-acting insulin use decreased significantly (p <.0001 for 2016 vs. 2017, 2017 vs. 2018; Table 5). This evidence concerns the gene INS and diabetes mellitus.